pioglitazone has been researched along with Inborn Errors of Metabolism in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ninomiya, H | 1 |
| Hirata, A | 1 |
| Kozawa, J | 1 |
| Nakata, S | 1 |
| Kimura, T | 1 |
| Kitamura, T | 1 |
| Yasuda, T | 1 |
| Otsuki, M | 1 |
| Imagawa, A | 1 |
| Kaneto, H | 1 |
| Funahashi, T | 1 |
| Shimomura, I | 1 |
1 other study available for pioglitazone and Inborn Errors of Metabolism
| Article | Year |
|---|---|
Treatment of Mitochondrial Diabetes with a Peroxisome Proliferator-activated Receptor (PPAR)-gamma Agonist.
Topics: Adiponectin; Blood Glucose; Diabetes Mellitus, Type 2; DNA, Mitochondrial; Female; Glucose Tolerance | 2016 |